Erlocip 150mg tablet- Erlotinib uses & side effects
Erlocip 150mg
Erlocip tablets consist of active ingredients known as Erlotinib (Generic Tarceva), that is considered as quinazoline derivative and anti-cancer agents that responses as a protein kinase prohibitors for EGFR related to tyrosine kinase.
Erlocip is majorly used in the treatment of non-small cell lung cancer and pancreatic carcinoma and also involved to treat various cancers. Erlocip is especially aimed the epidermal growth factor receptor tyrosine kinase.
Erlocip is majorly used in the treatment of non-small cell lung cancer and pancreatic carcinoma and also involved to treat various cancers. Erlocip is especially aimed the epidermal growth factor receptor tyrosine kinase.
USES OF Erlocip
Erlocip 150mg tablet is indicated as continuance therapy, in patients with long lasting or metastasis non small cell lung carcinoma, whose disease has not get advance after four cycles with platinum based first line therapy. Erlocipis used in this condition only after the failure of one prior chemotherapy regimen. No clinical advantages occur while using Erlocip with platinum based compounds like Carboplatin, gemcitabine or cisplatin.
Erlotinib Side effects
During the therapy, some undesirable effects, some of erlotinib side effects are as like; Paronychia, Bullous, blistering and expoliative skin conditions like Stevens Johnson’s syndrome. Gastrointestinal perforation Hepatic failure occurs during monotherapy or combination with other chemotherapy agents Some common side effects of Erlotinib are Diarrhea, Fatigue, Anorexia, Pruritus, Acne, Dermatitis, Dry skin, Loss of weight, Paronychia, Cough, Vomiting, Conjunctivitis, Keratoconjuctivities sicca, Abdominal pain, Stomatits, Infection, nausea, Bone pain, Alopecia, Anxiety, Neuropathy, Renal disorders, hepatic disorders, ocular disorders, skin, hair and nail disorders
Product Details
Trade name : Erlocip
Active ingredient : Erlotinib
Strength : 150mg
Manufactured by : Cipla
Pack : 30 tablets in a container
Active ingredient : Erlotinib
Strength : 150mg
Manufactured by : Cipla
Pack : 30 tablets in a container
PRESCRIPTION POLICY
Myapplepharma.com, a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.
Comments
Post a Comment